Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Mexico Eyes Investments From Indian Pharma
FDAnews Drug Daily Bulletin
Nov. 5, 2012
| Vol. 9 No. 217
Mexico Eyes Investments From Indian Pharma
Mexico is keen on investments from Indian pharmaceuticals and IT companies so that bi-lateral trade achieves the $10-billion mark by 2015 from the current level of $4 billion, said Ashank Desai, Founder of Mastek.
The Hindu Business Line
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Mylan Launches Generic Tricor Tablets
Is the FDA Approving too Many Drugs Starting with X and Z?
Court Rejects Merck Deal Over Vioxx
Citizens in Poor EU States Can’t Afford Medicines, Health Promoters Say